Biotech in Belgium: news and updates

News and Trends 5 Aug 2022

Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE

This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at Deep Science Ventures; Matthias Steger, CEO of Endogena Therapeutics; Rodolphe Besserve, CEO, and Georges Rawadi, chief of biotech studio development, at eureKARE; and Biotech Growth Trust portfolio manager, Geoff Hsu. Endogena Therapeutics to start clinical stage with treatment for blindness […]

August 5, 2022

In Depth 3 Aug 2022

The biggest European biotech investments in July 2022

The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic Biosciences. Life sciences manufacturing companies saw a big windfall in Europe in July 2022 as the Cork-based Normax Biomed bagged around $301 million. The firm is establishing modular manufacturing facilities that could provide mRNA vaccines […]

August 3, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Aug 2022

Clinical hold on trial for colorectal cancer drug lifted by FDA

A clinical hold has been lifted by the US Food and Drug Administration (FDA) on a trial for a treatment for colorectal cancer after changes were made by the company responsible. Belgium-based Celyad Oncology SA is a clinical biotech company focused on finding and developing chimeric antigen receptor T cell (CAR T) therapies for cancer. […]

August 1, 2022 - 2 minutesmins - By Liza Laws

News and Trends 19 Jul 2022

eureKARE launches synthetic biology studio network

eureKARE, a company focused on financing and building next generation biotech companies in the fields of synthetic biology, has launched its first synthetic biology studio in Belgium. In conjunction with this, eureKARE has appointed Georges Rawadi as chief of biotech studio development. eureKARE said its thematic synthetic biology studio model is a novel, flexible approach […]

July 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 14 Jul 2022

Agomab bags $114 million in thriving regenerative medicine sector

The Belgian company Agomab Therapeutics has topped up its Series B round by $40.5 million to hit $114 million. This Pfizer-led financing round extension is just the latest sign that the emerging field of regenerative medicine is coming to the fore. Agomab has embarked on an ambitious path to redefine how we understand regenerative medicine […]

July 14, 2022 - 3 minutesmins - By Victor Kotsev

News and Trends 28 Jun 2022

MRM Health starts pouchitis clinical trial

MRM Health, a Belgian clinical-stage biopharmaceutical company, has received regulatory approval from the Federal Agency for Medicines and Health Products (FAMHP) in Belgium to start a phase 2 trial with the novel next-generation optimized consortium therapy, MH002, in patients with pouchitis. MH002 is the first consortium therapy in which key disease-driving mechanisms guide therapeutic microbial […]

June 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 22 Jun 2022

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Belgian headquartered biotech Galapagos NV has acquired CellPoint and AboundBio, a move the Belgian company said propels it into next-generation cell therapy. Galapagos said the acquisitions give it access to an innovative, scalable, decentralized and automated point-of-care cell therapy supply model as well as a next-generation fully human antibody-based therapeutics platform. Galapagos said the goal […]

June 22, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

Biotalys and Novozymes partner on biofungicide

Belgian agtech company Biotalys and Danish biotech company Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol product. Novozymes will explore additional routes for the upscaling and production of the bioactive protein of Evoca, with the option of a possible commercial collaboration for a future generation of the product. […]

June 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 21 Jun 2022

New agreement could lead to first African-owned COVID-19 vaccine

A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together. The agreement intends to pave the way for the development of the first African-owned COVID-19 vaccine. The collaboration will focus on the development of a novel mRNA […]

June 21, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 16 Jun 2022

Gimv creates new fund for life science companies

European investment company Gimv has launched its fifth investment platform with a focus on venture capital investments in innovative life sciences companies. Gimv said after growth in its existing healthcare platform, a dedicated life sciences platform will strengthen its role in the international life science venture capital ecosystem. The company added its key investment focus […]

June 16, 2022 - 2 minutesmins - By Jim Cornall

radiopharmaceutical treatments precirix jeito

News and Trends 17 Mar 2022

€80M Series B Establishes European Champion in Radiopharmaceuticals

Big European venture capital firms Jeito, Forbion, and Inkef Capital have teamed up to propel the local radiopharmaceutical scene by investing €80M in the Belgian firm Precirix. Europe has a long history of expertise in the development of radiopharmaceutical drugs. One of the pioneers in the field was Advanced Accelerator Applications (AAA) in France. AAA […]

March 17, 2022 - 4 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy between European and Japanese life sciences. Japan boasts a world-class technology industry in addition to a thriving life sciences scene. The nation hosts large companies including Takeda, Eisai, and […]

February 18, 2022 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Belgium

Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE

The biggest European biotech investments in July 2022

Clinical hold on trial for colorectal cancer drug lifted by FDA

eureKARE launches synthetic biology studio network

Agomab bags $114 million in thriving regenerative medicine sector

MRM Health starts pouchitis clinical trial

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Biotalys and Novozymes partner on biofungicide

New agreement could lead to first African-owned COVID-19 vaccine

Gimv creates new fund for life science companies

€80M Series B Establishes European Champion in Radiopharmaceuticals

Belgian VC Fund Leads Investment Wave in Japanese Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!